Antihemophilic factor, human recombinant
برندهای حاوی ماده مؤثره Antihemophilic factor, human recombinant، نکتههای غذایی و مهمترین تداخلهای دارویی.
برندها
38- ADVATE 1000 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONبارکد: 8681429550028
- ADVATE 1500 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONبارکد: 8681429550035
- ADVATE 2000 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONبارکد: 8681429550042
- ADVATE 250 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONبارکد: 8681429550004
- ADVATE 500 IU/5 ML IV ENJEKSIYON ICIN LIYOFILIZE TOZ ICEREN FLAKONبارکد: 8681429550011
- ADYNOVATE 1000 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)بارکد: 8681429550509
- ADYNOVATE 1500 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)بارکد: 8681429550516
- ADYNOVATE 2000 IU/5ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)بارکد: 8681429550523
- ADYNOVATE 250 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)بارکد: 8681429550486
- ADYNOVATE 500 IU/2ML IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN LIYOFILIZE TOZ VE COZUCU (1 FLAKON)بارکد: 8681429550493
- BERIATE 1000 IU IV ENJEKSIYONLUK / INFUZYONLUK LIYOFILIZE TOZ VE COZUCUSUبارکد: 8681624980026
- BERIATE 500 IU IV ENJEKSIYONLUK / INFUZYONLUK LIYOFILIZE TOZ VE COZUCUSUبارکد: 8681624980019
- ELOCTA 1000 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU بارکد: 8683125910038
- ELOCTA 1500 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU بارکد: 8683125910045
- ELOCTA 2000 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU بارکد: 8683125910052
- ELOCTA 250 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU بارکد: 8683125910014
- ELOCTA 3000 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU بارکد: 8683125910069
- ELOCTA 500 IU IV ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU بارکد: 8683125910021
- EMOCLOT 1000 IU/10 ML IV INFUZYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8680972009038
- EMOCLOT 500 IU/10 ML IV INFUZYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8680972009021
- ESPEROCT 1000 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)بارکد: 8699676791194
- ESPEROCT 1500 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)بارکد: 8699676791200
- ESPEROCT 2000 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)بارکد: 8699676791217
- ESPEROCT 3000 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)بارکد: 8699676791224
- ESPEROCT 500 IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCU (1 FLAKON)بارکد: 8699676791187
- FANHDI 1000 IU 1 FLAKONبارکد: 8699769980078
- HAEMOCTIN SDH 500 IU / 10 ML IV ENJEKSIYONLUK TOZ VE COZUCU (1 FLAKON)بارکد: 8682109319829
- NOVOEIGHT 1000IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8699676790678
- NOVOEIGHT 1500IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8699676790685
- NOVOEIGHT 2000IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8699676790692
- NOVOEIGHT 3000IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8699676790708
- NOVOEIGHT 500IU ENJEKSIYONLUK COZELTI HAZIRLAMAK ICIN TOZ VE COZUCUبارکد: 8699676790661
- OCTANATE 1000 IU 1 FLAKONبارکد: 8699686980120
- OCTANATE 500 IU 1 FLAKONبارکد: 8699686980113
- REFACTO AF 1000 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONبارکد: 8681308274427
- REFACTO AF 2000 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONبارکد: 8681308274434
- REFACTO AF 250 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONبارکد: 8681308274403
- REFACTO AF 500 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU 1 FLAKONبارکد: 8681308274410
نکتههای غذایی
0نکته غذایی ثبتشدهای برای این ماده مؤثره وجود ندارد.
مهمترین تداخلها
10 مورد نخست از 50Alpha-1-proteinase inhibitor ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Aminocaproic acidمتوسط
خطر یا شدت عوارض جانبی ممکن است هنگام مصرف همزمان Aminocaproic acid با Antihemophilic factor, human recombinant افزایش یابد.
نمای تخصصی
The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor, human recombinant.
Aminomethylbenzoic acid ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Aprotininمتوسط
Aprotinin ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Aprotinin may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Camostatمتوسط
Camostat ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Camostat may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Hydrogen peroxideمتوسط
Hydrogen peroxide ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Menadioneمتوسط
Menadione ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Menadione may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Menadione bisulfiteمتوسط
Menadione bisulfite ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Menadione bisulfite may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Tranexamic acidمتوسط
Tranexamic acid ممکن است اثر لختهزا Antihemophilic factor, human recombinant را تقویت کند.
نمای تخصصی
Tranexamic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.
- Alteplaseجزئی
اثربخشی Antihemophilic factor, human recombinant ممکن است هنگام مصرف همزمان با Alteplase کاهش یابد.
نمای تخصصی
The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase.